On September 1, 2021 PHYNOVA Group Ltd ("Phynova") and Bioriginal Food & Science Corp ("Bioriginal") reported a partnership on Reducose, Phynova’s patented and clinically researched White Mulberry Leaf extract that supports significant lowering of post-meal blood sugar and insulin response (Press release, Phynova, SEP 1, 2021, View Source [SID1234587256]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The partnership will encompass both distribution to North American customers as well as joint promotion of the health benefits of Reducose. Bioriginal will serve customers with Reducose as a stand-alone ingredient or as a hero-ingredient in turn-key solutions.
Stephane Ducroux, CEO at Phynova, said: "We are excited to embark on our go-to-market partnership with Bioriginal in the North American market. Phynova’s strategy is to partner with market focused experts such as Bioriginal, who have a proven track record of building deep customer relationships, fast prototyping and turn-key solutions using ingredients with a strong science pedigree like Reducose.
Phynova produces Reducose 5%, a patented premium white mulberry leaf extract that can reduce the blood sugar and insulin response after a meal by up to 40%. Reducose is vegetarian, natural, allergen free and is backed by 6 human clinical studies. Most recently Phynova published the positive clinical trial results on Reducose in the peer-reviewed journal ‘Nutrition & Metabolism’. The full paper can be accessed here: View Source
"We are excited to partner with Phynova by bringing a unique ingredient into Bioriginal’s highly selective nutraceutical ingredient line", said Matt Phillips, Vice President of Sales at Bioriginal. "Phynova’s sustainable, unique and clinically researched white mulberry leaf extract perfectly complements our innovative ingredients portfolio and strengthens our offerings to the nutraceutical and food industries. We look forward to collaborating with Phynova and utilizing Reducose to formulate turnkey concepts – that our customers can quickly take to market – addressing consumer demands for a multitude of benefits."